Renal transplant rejection treatment: A cost-effective approach

A. Matas, V. Tellis, T. Quinn

Research output: Contribution to journalArticlepeer-review


This study demonstrated that graft survival is not decreased by initial antirejection treatment with MP. We did not hesitate to add ALG if there was continuing deterioration or no improvement in graft function. Forty percent of the first rejection episodes and 60% of the second rejection episodes in the MP group were eventually treated with ALG. However, a large number of patients were spared the time, inconvenience, and expense of ALG treatment. We conclude that MP alone, with ALG added if treatment fails, is a cost-effective method to treat rejection in patients receiving prednisone and azathioprine as basic immunosuppression.

Original languageEnglish (US)
Pages (from-to)189-190
Number of pages2
JournalTransplantation Proceedings
Issue number1 I
StatePublished - Jan 1 1985

ASJC Scopus subject areas

  • Surgery
  • Transplantation


Dive into the research topics of 'Renal transplant rejection treatment: A cost-effective approach'. Together they form a unique fingerprint.

Cite this